MAJOR PHARMACEUTICALS, INC. – Trademark Portfolio
Entity Type: 03
MAJOR PHARMACEUTICALS, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MAJOR. The owner is based in CHICAGO, IL.
1640 W. FULTON STREET
CHICAGO, IL 60612
Showing of trademarks Trademarks
Trademark Classifications
MAJOR PHARMACEUTICALS, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does MAJOR PHARMACEUTICALS, INC. have?
MAJOR PHARMACEUTICALS, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 3 cancelled.
What trademark classes does MAJOR PHARMACEUTICALS, INC. file in?
MAJOR PHARMACEUTICALS, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are MAJOR PHARMACEUTICALS, INC.'s most well-known trademarks?
MAJOR PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as MAJOR. These are among 1 currently registered trademark in the portfolio.
What is MAJOR PHARMACEUTICALS, INC.'s trademark registration success rate?
MAJOR PHARMACEUTICALS, INC. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.